8th Mar, 2021 | Information
Medical and Healthcare products Regulatory Agency (MHRA) 17/1/21:Ref. Roles and Responsibilities-Reporting of Adverse Side Effects and/or Allergic Reaction to Medication “The scheme is not compulsory: it is voluntary for both healthcare professionals and members of...
8th Mar, 2021 | Information
https://bnf.nice.org.uk/guidance/adverse-reactions-to-drugs.html Suspected adverse drug reactions should be reported through the Yellow Card Scheme at www.mhra.gov.uk/yellowcard………Spontaneous reporting is particularly valuable for recognising...
8th Mar, 2021 | Information
14C) www.mhra.gov.uk/yellowcard www.gov.uk/yellowcard For established (or non-black triangle) medicines the MHRA select signals for further analysis which meet a set of criteria. These criteria include, for example, all ADRs which occur in children or any which...
8th Mar, 2021 | Information
https://www.medicalnewstoday.com/articles/mirtazapine-oral-tablet#important-warnings FDA warning: Suicide risk: “This drug has a black box warning. This is the most serious warning from the Food and Drug Administration (FDA). A black box warning alerts doctors and...
8th Mar, 2021 | Information
https://www.fda.gov/international-programs/confidentiality-commitments/mhra-uk-fda-confidentiality-commitment MHRA UK – FDA : CONFIDENTIALITY COMMITMENT THE UNITED KINGDOM MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY: The MHRA acknowledges that the FDA,...
